ArticleBMC microbiology2026
Functional impact of a conservative missense mutation in the Mycobacterium bovis BCG Moreau heat shock response regulator hrcA gene.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe genus Mycobacterium includes important human pathogens such as M. tuberculosis, the etiological agent of human tuberculosis. A critical factor in its pathogenic success is its ability to adapt efficiently to various stress conditions, including heat shock. This response mitigates the accumulation of misfolded proteins by upregulating heat shock proteins, primarily chaperones, through complex regulatory networks, including transcriptional repressors such as HspR and HrcA. The vaccine strain M. bovis BCG Moreau genotypically differs from M. tuberculosis in several aspects, including a conservative missense mutation in hrcA, substituting valine with leucine at residue 67 near its DNA-binding domain. This genetic variation could impact stress adaptation and vaccine-associated traits through altered regulation of heat shock proteins.
resultsStructural modeling of BCG Moreau's HrcA revealed local rearrangements accommodating the larger leucine side chain, with maintained overall protein architecture. Electrophoretic mobility shift assays (EMSA) demonstrated reduced binding of Moreau's HrcA to CIRCE elements upstream of groES and groEL2 compared to the BCG Pasteur strain. RT-qPCR revealed unexpected patterns, with greater transcriptional induction of the groES operon and groEL2 in the Pasteur strain under heat shock conditions. Western blotting analysis corroborated these findings, showing increased GroEL2 levels in both intracellular and secreted fractions of BCG Pasteur. These observations suggest the involvement of multiple regulatory layers beyond direct HrcA-mediated repression.
conclusionsOur findings suggest that M. bovis BCG Moreau may employ distinct mechanisms to modulate its heat shock response, with the V67L mutation in HrcA potentially contributing to these differences. The lower baseline expression of immunogenic heat shock proteins in BCG Moreau, combined with its distinct regulatory response to stress, may explain its reported characteristics of reduced adverse reactions while maintaining protective immunity. These results provide new insights into strain-specific variations in heat shock protein regulation and their potential impact on vaccine performance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.